Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients (2017)
- Authors:
- USP affiliated authors: LANCHOTE, VERA LUCIA - FCFRP ; COELHO, EDUARDO BARBOSA - FMRP
- Unidades: FCFRP; FMRP
- DOI: 10.1016/j.ejps.2017.05.033
- Subjects: FARMACOLOGIA; DIABETES MELLITUS; ANTAGONISMO DE DROGAS
- Keywords: Carvedilol; Enantiomers; Population pharmacokinetics; Type 2 diabetes; Stereoselective metabolism
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: European Journal of Pharmaceutical Sciences
- ISSN: 0928-0987
- Volume/Número/Paginação/Ano: v. 109S, p. S108-S115, 2017
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
NARDOTTO, Glauco H. B et al. Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients. European Journal of Pharmaceutical Sciences, v. 109S, p. S108-S115, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2017.05.033. Acesso em: 19 abr. 2024. -
APA
Nardotto, G. H. B., Lanchote, V. L., Coelho, E. B., & Della Pasqua, O. (2017). Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients. European Journal of Pharmaceutical Sciences, 109S, S108-S115. doi:10.1016/j.ejps.2017.05.033 -
NLM
Nardotto GHB, Lanchote VL, Coelho EB, Della Pasqua O. Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients [Internet]. European Journal of Pharmaceutical Sciences. 2017 ; 109S S108-S115.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/j.ejps.2017.05.033 -
Vancouver
Nardotto GHB, Lanchote VL, Coelho EB, Della Pasqua O. Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients [Internet]. European Journal of Pharmaceutical Sciences. 2017 ; 109S S108-S115.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/j.ejps.2017.05.033 - Enantioselective pharmacokinetics of lercanidipine in healthy volunteers
- Influence of lercanidipine in the kinetic sisposition of fluvastatin enantiomers in healthy volunteers
- Enantioselective analysis of citalopram and demethylcitalopram in human and rat plasma by chiral LC-MS/MS: application to pharmacokinetics
- Analysis of carvedilol enantiomers in human plasma using chiral stationary phase column and liquid chromatography with tandem mass spectrometry
- Stereoselective analysis of metoprolol and its metabolites inrat plasma with application to oxidative metabolism
- Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism
- Lercanidipine-fluvastatin interaction: pharmacokinetics stereoselectivity in experimental study
- Effect of hypertension on the stereoselective pharmacokinetics of fluvastatin in rats
- Enantioselectivity in fluvastatin-lercanidipine pharmacokinetics interaction in healthy volunteers
- Enantioselectivity in the pharmacokinetic interaction between fluvastatin and lercanidipine in healthy volunteers
Informações sobre o DOI: 10.1016/j.ejps.2017.05.033 (Fonte: oaDOI API)
Download do texto completo
Tipo | Nome | Link | |
---|---|---|---|
002916837.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas